Internal Medicine, Hematology & Oncology · Belleville, NJ
NPI
1659516813
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
1 Clara Maass Dr Ste 200
Belleville, NJ, 07109
Phone (973) 751-8880
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
92,893 services
Medicare patients, 2024
549
Average age 76
Drug cost, 2024
$2.6M
3,528 prescriptions
Company payments, 2025
$726
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Orsini Jr. was code J1453 (injection, fosaprepitant, 1 mg), 10,200 times for 12 patients. In total James M Orsini Jr. billed 92,893 services in 110 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,200 | 12 | $0.11 | $1,153 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,200 | 15 | $0.09 | $108 |
| 36415 Venipuncture Blood Collection | Office | 814 | 214 | $8.65 | $7,041 |
| 85025 Blood Count | Office | 771 | 210 | $7.61 | $5,867 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 710 | 13 | $0.72 | $511 |
| 99232 Hospital E&M - Subsequent | Facility | 637 | 228 | $66.09 | $42K |
| 99214 Office E&M - Established | Office | 381 | 181 | $103.97 | $40K |
| 96413 Chemotherapy Administration | Office | 280 | 33 | $115.62 | $32K |
| 99213 Office E&M - Established | Office | 263 | 96 | $74.86 | $20K |
| 99310 SNF E&M | Facility | 256 | 52 | $130.91 | $34K |
| 96367 Intravenous Infusion, Hydration | Office | 247 | 38 | $25.24 | $6,233 |
| 96372 Injection Administration | Office | 157 | 33 | $12.27 | $1,926 |
| 99222 Hospital E&M - Initial | Facility | 150 | 136 | $107.71 | $16K |
| 96375 Injection Administration | Office | 134 | 20 | $13.79 | $1,847 |
| 99309 SNF E&M | Facility | 129 | 41 | $91.90 | $12K |
By year: 2022 $1.2M for 63,818 services; 2023 $2.2M for 97,882 services; 2024 $2.1M for 92,893 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 814 | 214 | $8.65 | $7,041 |
| 85025 Blood Count | 771 | 210 | $7.61 | $5,867 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Orsini Jr. prescribed most often to Medicare patients was Eliquis (Apixaban), with 270 prescriptions and refills. In total James M Orsini Jr. wrote 3,528 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 270 | 312 | 62 | $138K |
| Atorvastatin Calcium Generic | 189 | 193 | 29 | $2,725 |
| Pantoprazole Sodium Generic | 111 | 121 | 18 | $916 |
| Amlodipine Besylate Generic | 105 | 109 | 20 | $643 |
| Mirtazapine Generic | 83 | 87 | 15 | $1,800 |
| Sertraline Hcl Generic | 79 | 81 | 11 | $751 |
| Metoprolol Succinate Generic | 76 | 82 | 12 | $939 |
| Tamsulosin Hcl Generic | 70 | 70 | 12 | $1,412 |
| Furosemide Generic | 62 | 62 | 12 | $329 |
| Prednisone Generic | 61 | 71 | 17 | $289 |
| Levothyroxine Sodium Generic | 58 | 60 | 11 | $518 |
| Januvia Sitagliptin Phosphate | 58 | 58 | Under 11 | $15K |
| Metformin Hcl Generic | 54 | 62 | Under 11 | $672 |
| Gabapentin Generic | 52 | 52 | 14 | $578 |
| Famotidine Generic | 52 | 52 | Under 11 | $764 |
Brand drugs: - claims; generic drugs: 2,663 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Orsini Jr. $726 ($726 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $119.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $119 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $90.14 |
| Merck Sharp & Dohme LLC MRK | 5 | $76.1 |
| Karyopharm Therapeutics Inc. KPTI | 4 | $66.04 |
| Geron Corporation GERN | 4 | $59.49 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $58.87 |
| Genzyme Corporation SNY | 2 | $40.48 |
| Abbvie Inc. ABBV | 2 | $35.71 |
| Gilead Sciences, Inc. GILD | 2 | $31.89 |
| Incyte Corporation INCY | 1 | $21.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.